Cell-free amino acid incorporation using ribosomes from strains of either Clostridium perfringens or Bacteroides fragilis was shown to be susceptible to inhibition by streptomycin and gentamicin. Ribosomes bound dihydrostreptomycin as effectively as ribosomes from Escherichia coli. No inactivation of streptomycin or gentamicin was detected by cell extracts of either anaerobic bacterial species. B. fragilis, grown without added hemin, menadione, and fumarate, and C. perfringens did not show any time-dependent accumulation of dihydrostreptomycin or gentamicin at concentrations tested. Decreased resistance to aminoglycosides and time-dependent uptake of dihydrostreptomycin at 500 ,ug/ml was observed with B. fragilis grown with hemin, menadione, and fumarate. With the last additions, cytochrome b was detected by cytochrome spectra of B.fragilis. These results demonstrate that anaerobic bacteria unable to carry out oxygen-or nitrate-dependent electron transport are resistant to streptomycin and gentamicin because of failure to transport aminoglycosides. The induction of fumarate-dependent electron transport in B. fragilis is associated with some aminoglycoside transport that is of poor efficiency relative to bacteria with electron transport to oxygen or nitrate.The strictly anaerobic bacteria Clostridium perfringens and Bacteroides fragilis are resistant to aminoglycosides. Streptomycin and gentamicin are not effectively transported into facultatively anaerobic bacteria under anaerobic conditions (2, 3). They are transported, although less effectively, if nitrate is provided in place of oxygen as a terminal electron acceptor in Escherichia coli and Pseudomonas aeruginosa (H. M. Van Den Elzen and L. E. Bryan, unpublished data). Recently a model has been proposed for the entry of aminoglycosides into bacteria (4) which could account for these observations. The model proposes that initial aminoglycoside entry (energy-dependent phase I [4]) is most effectively driven by energy obtained from electron transport using oxygen (or, alternatively, nitrate) as a terminal electron acceptor. This energy is used to create a receptor state for aminoglycoside binding and transport by a component of the cytoplasmic membrane. This component could be a transport carrier utilized by some other solute (or solutes) or, less likely, specific for aminoglycosides. The possibility of this type of carrier seems unlikely, in our opinion, because of the inability to demonstrate transport competition during energy-dependent phase I with a series of compounds structurally related to aminoglycosides and streptomycin.